IVF · NASDAQ
INVO Fertility (IVF) Stock Price & Fundamentals
INVO Fertility (IVF) closed at $273.90 on Oct 9, 2026, up 1.21% from the previous close of $270.63.
Share price, past year
1Y −10.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $273.90 |
| Sep 30, 2026 | $269.09 |
| Aug 31, 2026 | $277.29 |
| Jul 31, 2026 | $263.10 |
| Jun 30, 2026 | $263.48 |
| May 29, 2026 | $265.98 |
| Apr 30, 2026 | $259.78 |
| Mar 31, 2026 | $264.34 |
| Feb 27, 2026 | $285.85 |
| Jan 30, 2026 | $294.54 |
| Dec 31, 2025 | $313.22 |
| Nov 28, 2025 | $300.22 |
| Oct 31, 2025 | $304.27 |
Key statistics
- Market cap
- $628.61M
- P/E (TTM)
- 0.1
- EPS (TTM)
- $3,620.49
- Revenue (TTM)
- $7.53M
- Net income (TTM)
- −$6.95M
- Shares outstanding
- 2.3M
- Dividend yield
- —
- 52-week range
- $248.71 – $313.22
INVO Fertility's market cap is $628.61M, based on a share price of $273.90 and 2.3M shares outstanding as of Jun 30, 2026.
Financials
INVO Fertility reported revenue of $6.84M for fiscal 2025, up 4.73% from fiscal 2024.
INVO Fertility reported a net loss of $23.32M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $6.84M | +4.7% | −$23.32M | −340.9% | −$214.64 | −$7.06M |
| FY2024ended Dec 31, 2024 | $6.53M | +116.3% | −$9.26M | −141.8% | −$3,782.65 | −$3.16M |
| FY2023ended Dec 31, 2023 | $3.02M | +267.4% | −$8.03M | −266.0% | −$67.37 | −$5.20M |
| FY2022ended Dec 31, 2022 | $822.20K | −80.2% | −$10.89M | −1,324.8% | −$17.97 | −$6.61M |
| FY2021ended Dec 31, 2021 | $4.16M | +301.1% | −$6.65M | −160.0% | −$0.63 | −$6.45M |
| FY2020ended Dec 31, 2020 | $1.04M | −29.9% | −$8.35M | −804.7% | −$1.52 | −$4.82M |
| FY2019ended Dec 31, 2019 | $1.48M | +199.4% | −$2.17M | −146.4% | −$0.45 | $1.31M |
| FY2018ended Dec 31, 2018 | $494.38K | +75.2% | −$3.08M | −622.2% | −$0.02 | −$672.37K |
| FY2017ended Dec 31, 2017 | $282.15K | +454.3% | −$702.16K | −248.9% | $0.00 | −$181.27K |
| FY2016ended Dec 31, 2016 | $50.90K | — | −$2.12M | −4,173.3% | −$0.02 | −$339.60K |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.18M | $888.74K | $0.35 |
| Q1 FY2026ended Mar 31, 2026 | $2.02M | −$5.54M | −$3.38 |
| Q4 FY2025ended Dec 31, 2025 | $1.58M | $1.10M | $3,662.92 |
| Q3 FY2025ended Sep 30, 2025 | $1.76M | −$3.40M | −$39.40 |
| Q2 FY2025ended Jun 30, 2025 | $1.86M | −$3.62M | −$364.23 |
| Q1 FY2025ended Mar 31, 2025 | $1.64M | −$17.40M | −$3,473.93 |
| Q4 FY2024ended Dec 31, 2024 | $1.69M | −$3.79M | −$3,737.60 |
| Q3 FY2024ended Sep 30, 2024 | $1.43M | −$1.63M | −$15.11 |
Company profile
- Name
- INVO Fertility, Inc.
- Ticker
- IVF
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 5582 Broadcast Court, Sarasota, FL 34240
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001417926
Recent SEC filings
- Aug 28, 2026
- Aug 17, 2026
- Aug 14, 2026
- Jul 24, 2026
- Jun 25, 2026
- Jun 22, 2026
- Jun 22, 2026
- Jun 16, 2026
Frequently asked questions
What is INVO Fertility's stock price?
INVO Fertility (IVF) closed at $273.90 on Oct 9, 2026, up 1.21% from the previous close of $270.63.
What is INVO Fertility's market cap?
INVO Fertility's market cap is $628.61M, based on a share price of $273.90 and 2.3M shares outstanding as of Jun 30, 2026.
How much revenue does INVO Fertility make?
INVO Fertility reported revenue of $6.84M for fiscal 2025, up 4.73% from fiscal 2024.
What is IVF's P/E ratio?
INVO Fertility's price-to-earnings ratio is 0.1, based on trailing twelve-month diluted EPS of $3,620.49.
Does INVO Fertility pay a dividend?
INVO Fertility's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from INVO Fertility, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures